Organigram Holdings | OGI - 股本和储备



金融业
股票价格
CAD
资产
CAD 521.31M
现金及等价物
CAD 4.29M
销售成本
CAD 43.39M
流动资产
CAD 250.09M
流动负债
CAD 88.75M
债务
CAD 8.2M
EBIT
CAD -9.79M
EBITDA
CAD -4.76M
员工
1.14K
EPS每股收益
CAD -0.01
股本和储备
CAD 371.81M
销售毛利
CAD 16.41M
债务利息支出
CAD 179K
贷款资金
CAD 60.76M
市值
CAD 164.38M
净收入
CAD -921K
营业费用
CAD 69.59M
营业利润
CAD -9.79M
普通股股本
CAD 136.47M
PE价格收益
12.01
税前利润
CAD -921K
销售收入
CAD 59.79M
销售和管理费用
CAD 22.01M
股票
CAD 135.16M
贸易债权人
CAD 73.14M
应收帐款人
CAD 53.39M


股本和储备 更改 日
Acasti Pharma USD 64.89M 2.07M 2025-12
Akebia Therapeutics USD 25.02M 2.36M 2026-06
Alaunos Therapeutics USD 1.29M 865K 2026-03
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Avita Medical AUD -16.65M 3.76M 2025-12
Canopy Growth CAD 697.59M 60.58M 2026-03
Cronos Group USD 1.07B 4.99M 2026-06
Dianthus Therapeutics USD 1.17B 29.29M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Knight Therapeutics CAD 767.27M 480K 2025-12
Moderna USD 6.76B 647M 2026-06
Organigram Holdings CAD 371.81M 2.36M 2026-03
Organon & Co USD 1.01B 103M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 14.26B 397.3M 2026-06
Xeris Pharmaceuticals USD -9.73M 22.74M 2026-06